Optimization of Health before Surgery: Lessons from the ACS Strong for Surgery Program and Rethinking Clinical Care Models during the Pandemic
This activity has been archived and credit is no longer available.
In this session of the annual William D. Seybold Distinguished Lectureship, Dr. Thomas Varghese discusses the American College of Surgeon's Strong for Surgery Quality Improvement Program, including: design principles, lessons learned, and ways in which surgical care has been impacted by the COVID-19 pandemic.
This Michael E. DeBakey Department of Surgery Grand Rounds session took place on Wednesday, March 31, 2021 at 7:00 A.M.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
General, plastic, thoracic, vascular, cardiothoracic, abdominal transplantation and surgical oncology physicians, residents, fellows and medical students need to be regularly updated on novel therapies, as well as advances in surgical care and clinical practices that will aid them in treating a variety of surgical procedures to increase the patient care experience and improve practice efficiency.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Identify and evaluate evidence-based practices to optimize the health of patients before surgery.
- Explain the design principles of the American College of Surgeons Strong for Surgery quality program and summarize lessons learned from participating sites across the nation.
- Discuss key factors in pre-surgical care that have been impacted by the COVID-19 pandemic.
- Detail a vision for the future to improve surgical practices and population health.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
Specialties
- Surgery
Interest Groups
- COVID
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Thomas K. Varghese, M.D., M.S., FACS
Interim Executive Medical Director and Chief Value Officer
Huntsman Cancer Institute, University of Utah
Disclosure:
Nothing to disclose.
Activity Director
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Michele Loor, M.D., FACS
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Todd Rosengart, M.D., F.A.C.S.
DeBakey-Bard Chair of Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: